Truvada: Recommended for pre-exposure prophylaxis (PrEP)

The United States FDA‘s advisory committee has recommended that Truvada should be approved for HIV prophylaxis. Gilead Sciences Inc is the manufacturer of the drug to be used in combination therapy of AIDS. The drug is a RTI (Reverse Transcriptase Inhibitor), although it can not destroy the virus but stops their replication. Truvada consists of Emtricitabine and Tenofovir Disoproxil Fumarate […]

» Read more